ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline Jun 18, 2026 03:54PM
Grabar Law Office Investigates ADMA Biologics, Inc. (ADMA) on Behalf of Long-Term Shareholders Jun 18, 2026 08:16AM
ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline Jun 17, 2026 03:48PM
ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline Jun 16, 2026 03:44PM
ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline Jun 15, 2026 02:34PM


Jun 12, 2026 05:26PM ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Jun 11, 2026 03:09PM ADMA Biologics Investors Should Contact Block & Leviton By August 10th to Lead Class Action Lawsuit
Jun 10, 2026 07:03AM Raymond James Starts ADMA Biologics (ADMA) at Outperform
May 11, 2026 01:47PM ADMA Biologics Investors Should Contact Block & Leviton to Possibly Recover Losses Through The Firm's Investigation
May 7, 2026 09:16AM ADMA Biologics Stock Alert (ADMA) - Kehoe Law Firm, P.C. Investigating Potential Securities Claims on Behalf of ADMA Biologics Investors
May 7, 2026 08:20AM ADMA Biologics Investigated for Securities Fraud; Investors Should Contact Block & Leviton to Possibly Recover Losses
May 6, 2026 04:50PM ADMA Biologics (ADMA) Misses Q1 EPS by 1c, Offers Guidance
Mar 30, 2026 01:49AM Increasing unusual call option volume: ADMA CANE DBA PTEN PRCT COUR JBS
Mar 27, 2026 07:00AM ADMA Biologics refutes short seller allegations about products
Mar 26, 2026 02:43PM ADMA Biologics (ADMA) June 10 and 15 calls active, share price down 18.4%
Mar 26, 2026 10:24AM Increasing unusual call option volume: ADMA MLCO ESTC NEXT BZAI JBS CHPT NAVN TERN
Mar 26, 2026 03:46AM Cantor Fitzgerald Downgrades ADMA Biologics (ADMA) to Neutral
Mar 25, 2026 06:31AM ADMA Biologics disputes short-seller report claims
Mar 24, 2026 01:52PM ADMA Biologics shares plunge on short seller allegations
Mar 24, 2026 01:43PM Culper Research is short ADMA Biologics (ADMA)
Feb 26, 2026 12:50AM ADMA Biologics (ADMA) Tops Q4 EPS by 1c ; Offers Guidance
Jan 12, 2026 08:10AM ADMA Biologics reports $510-511 million 2025 revenue, raises 2026 outlook
Jan 12, 2026 05:26AM ADMA Biologics (ADMA) call put ratio 1 call to 4.2 puts with a focus on January 17, 18 and 19 puts
Dec 4, 2025 07:45AM These stocks are new additions to Mizuho's 'Americas Top Picks' list
Nov 5, 2025 05:15PM ADMA Biologics (ADMA) Reports In-Line Q3 EPS, provides guidance
Aug 7, 2025 02:08AM ADMA Biologics (ADMA) Misses Q2 EPS by 1c
May 8, 2025 09:47AM Increasing unusual put option volume: ADMA ASPN MSOS PR BE FLNC CVE GXO TAP AXON
Apr 28, 2025 07:02AM ADMA Biologics (ADMA) Announces U.S. FDA Approval of Innovative Production Yield Enhancement Process
Apr 15, 2025 01:57PM ADMA Biologics (ADMA) spreader of 3K contracts of April 19 and May 22 calls as share price up 4.3%
Apr 7, 2025 07:01AM ADMA Biologics (ADMA) Issues Statement on Tariffs
Mar 15, 2025 04:00PM Bernstein provides 2025 M&A outlook for U.S. Biotech and Pharma
Mar 6, 2025 06:48AM ADMA Biologics (ADMA) PT Raised to $32 at Mizuho
Mar 4, 2025 09:13AM Cantor Fitzgerald Reiterates Overweight Rating on ADMA Biologics (ADMA)
Mar 3, 2025 04:20PM ADMA Biologics (ADMA) Tops Q4 EPS by 31c, Offers Guidance
Jan 16, 2025 05:00AM Options with decreasing option implied volatility: MNKD AEHR AUR GME IRBT ADMA CONY
Dec 17, 2024 06:45AM ADMA Biologics (ADMA) PT Raised to $28 at Mizuho
Dec 3, 2024 06:52AM Mizuho Reiterates Outperform Rating on ADMA Biologics (ADMA)
Dec 2, 2024 03:52PM ADMA Biologics (ADMA) call put ratio 1.6 calls to 1 put on active options volume of 16K contracts
Nov 19, 2024 07:19AM Mizuho Reiterates Outperform Rating on ADMA Biologics (ADMA)
Nov 8, 2024 02:53PM ADMA Biologics (ADMA) Tops Q3 EPS by 2c
Oct 14, 2024 06:58AM H.C. Wainwright Reiterates Buy Rating on ADMA Biologics (ADMA)
Oct 10, 2024 12:48PM Mizuho Healthcare Desk Distributes Comments on ADMA Biologics (ADMA) Weakness Post Call, Shares Down ~20%
Sep 17, 2024 07:00AM ADMA Biologics (ADMA) to Join S&P SmallCap 600 Index
Sep 6, 2024 06:28PM Zurn Elkay Water, Clear Secure, TG Therapeutics, others to join S&P SmallCap 600
Aug 14, 2024 08:59AM ADMA Biologics (ADMA) Announces Partial Paydown of Revolving Credit Facility
Aug 12, 2024 06:51AM ADMA Biologics (ADMA) PT Raised to $18 at H.C. Wainwright
Aug 8, 2024 04:09PM ADMA Biologics (ADMA) Tops Q2 EPS by 5c ; Offers Guidance
Jun 20, 2024 06:48AM ADMA Biologics (ADMA) PT Raised to $14 at Mizuho